Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers

por Heerspink, H. J. L., Johnsson, E., Gause‐Nilsson, I., Cain, V. A., Sjöström, C. D.
Publicado 2016

[(18)F]FDG and [(18)F]NaF as PET markers of systemic atherosclerosis progression: A longitudinal descriptive imaging study in patients with type 2 diabetes mellitus

por Reijrink, M., de Boer, S. A., te Velde-Keyzer, C. A., Sluiter, J. K. E., Pol, R. A., Heerspink, H. J. L., Greuter, M. J. W., Hillebrands, J. L., Mulder, D. J., Slart, R. H. J. A.
Publicado 2021